USFDA approves Pfizer supplemental New Drug Application for EUCRISA (crisaborole) ointment for children with eczema Medical Dialogues Bureau29 March 2020 5:57 AMAD is a chronic skin disease characterized by inflammation of the skin and skin barrier defects